EPISODE · May 27, 2026 · 5 MIN
UK Alignment Acceleration and EU JCA Implementation
Episode 9 — 27 May 2026 Marcus and Sara examine the NICE-MHRA aligned pathway's potential to accelerate UK medicine access by six months and debate whether 50 EU joint clinical assessments starting this year represents genuine coordination or administrative overhead. They disagree on US drug pricing policy effectiveness and discuss expanding international HTA collaboration benefits. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access landscape. Full transcript and sources at outcomes-analytica.no/podcast
What this episode covers
Episode 9 — 27 May 2026 Marcus and Sara examine the NICE-MHRA aligned pathway's potential to accelerate UK medicine access by six months and debate whether 50 EU joint clinical assessments starting this year represents genuine coordination or administrative overhead. They disagree on US drug pricing policy effectiveness and discuss expanding international HTA collaboration benefits. Hosted by Marcus and Sara. Access Brief — Daily briefings on HEOR, HTA strategy and the evidence access lands...
NOW PLAYING
UK Alignment Acceleration and EU JCA Implementation
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Jan 2, 2026 ·47m
Dec 21, 2025 ·46m